• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Immunocore Holdings plc - American Depositary Shares (NQ:IMCR)

31.45 +0.07 (+0.22%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Immunocore Holdings plc - American Depositary Shares

< Previous 1 2 3 Next >
News headline image
KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma
April 19, 2026
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference
April 06, 2026
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting
March 17, 2026
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore to present at upcoming investor conferences
March 03, 2026
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore reports fourth quarter and full year 2025 financial results and provides a business update
February 25, 2026
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025
February 18, 2026
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore announces R&D leadership evolution
January 30, 2026
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference
January 09, 2026
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore to present at upcoming investor conferences
November 10, 2025
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore presents Phase 1 data for hepatitis B candidate at AASLD’s The Liver Meeting
November 07, 2025
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore reports third quarter financial results and provides a business update
November 06, 2025
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore to present at upcoming investor conferences
September 04, 2025
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore reports second quarter financial results and provides a business update
August 07, 2025
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore to report second quarter 2025 financial results and host call on August 7, 2025
July 31, 2025
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore to present at the 2025 Jefferies Global Healthcare Conference
June 02, 2025
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore reports first quarter financial results and provides a business update
May 07, 2025
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore to present at upcoming investor conferences
April 02, 2025
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025
March 10, 2025
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore to present at upcoming investor conferences
March 03, 2025
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore reports fourth quarter and full year 2024 financial results and provides a business update
February 26, 2025
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025
February 19, 2025
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore announces strategic priorities at 43rd Annual J.P. Morgan Healthcare Conference
January 10, 2025
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore to present at the 43rd Annual J.P. Morgan Healthcare Conference
January 06, 2025
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development
January 02, 2025
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore announces first patient dosed in the Phase 1 trial of IMC-P115C, a half-life extended (HLE) ImmTAC candidate in patients with tumors that express PRAME
December 23, 2024
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore announces treatment of first patient in the Phase 1/2 trial of IMC-R117C targeting PIWIL1 in advanced gastrointestinal cancers
December 17, 2024
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma
December 11, 2024
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore announces reimbursement agreement in England for KIMMTRAK▼ for the treatment of HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma
December 03, 2024
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore to present at upcoming investor conferences
November 08, 2024
From Immunocore Holdings plc
Via GlobeNewswire
News headline image
Immunocore reports third quarter financial results and provides a business update
November 06, 2024
From Immunocore Holdings plc
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap